Résultats de recherche - Portail des modèles médicaux de données (portail MDM)

Filtrer les résultats de recherche
Sélectionner modèles de données

Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

63 Résultats de recherche.

Response - Baseline Solid Tumor Evaluation Form - 2278273v3.0 - Baseline Solid Tumor Evaluation Form

- 09/01/2015 - 1 Formulaire, 4 Groupes Item, 23 Eléments de données, 1 Langue

Groupes Item: CRF Header, Target Lesion(s) Baseline Evaluation, Nontarget Lesion(s) Baseline Evaluation, Comments

Baseline Solid Tumor Evaluation Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D8884142-76F1-00F9-E034-0003BA12F5E7

Southwest Oncology Group Baseline Tumor Assessment Form

- 03/07/2015 - 1 Formulaire, 4 Groupes Item, 19 Eléments de données, 1 Langue

Groupes Item: SWOG clinical trial administrative data, Tumor assessment, Comments, CCRR MODULE

Southwest Oncology Group Baseline Tumor Assessment Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A50B77BD-3730-1660-E034-080020C9C0E0

E5508 Baseline Disease Evaluation Form (RECIST 1.1) NCT01107626

- 16/06/2015 - 1 Formulaire, 7 Groupes Item, 26 Eléments de données, 1 Langue

Groupes Item: Header Module, Data amendment, TARGET LESIONS, TARGET LESIONS - NON NODAL, TARGET LESIONS - NODAL, NONTARGET LESIONS, Comments

E5508 Baseline Disease Evaluation Form (RECIST 1.1) NCT01107626 Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6D42B202-CDD6-89E9-E040-BB89AD430258

E1208 Baseline Disease Evaluation Form (RECIST) NCT01004978

- 16/06/2015 - 1 Formulaire, 6 Groupes Item, 30 Eléments de données, 1 Langue

Groupes Item: Header Module, Patient demographics, Data amendment, TARGET LESIONS, NONTARGET LESIONS, Comments

E1208 Baseline Disease Evaluation Form (RECIST) NCT01004978 Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6FC99A84-9671-F189-E040-BB89AD4377B4

Southwest Oncology Group S0819 Baseline Tumor Assessment Form NCT00946712

- 09/06/2015 - 1 Formulaire, 4 Groupes Item, 21 Eléments de données, 1 Langue

Groupes Item: Header, Evaluation of lesions, Diagnostic test, COMMENTS

Southwest Oncology Group S0819 Baseline Tumor Assessment Form NCT00946712 Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=684CF883-62F5-1929-E040-BB89AD4373A3

ECOG4599 Baseline Disease Evaluation Form (RECIST)

- 28/05/2015 - 1 Formulaire, 1 Groupe Item, 27 Eléments de données, 1 Langue

Groupe Item: Baseline Disease Evaluation Data

ECOG4599 Baseline Disease Evaluation Form (RECIST) Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A1317E8C-0271-4779-E034-080020C9C0E0

Lung Cancer NCT01336894 Toxicity - ACOSOG-Z4099 Baseline Adverse Event Form - 3177833v1.0 - ACOSOG-Z4099 Baseline Adverse Event Form

- 09/01/2015 - 1 Formulaire, 3 Groupes Item, 10 Eléments de données, 1 Langue

Groupes Item: Header Module, Visit, Required Baseline Adverse Events from Section 8 of Protocol

ACOSOG-Z4099 Baseline Adverse Event Form Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9805AE2C-90B9-70EF-E040-BB89AD431611

Lung Cancer NCT00738881 Treatment - North Central Cancer Treatment Group N0723 Concurrent Treatment Form - Baseline - 2731645v1.0 - North Central Cancer Treatment Group N0723 Concurrent Treatment Form - Baseline

- 08/01/2015 - 1 Formulaire, 2 Groupes Item, 9 Eléments de données, 1 Langue

Groupes Item: Header, Header

North Central Cancer Treatment Group N0723 Concurrent Treatment Form - Baseline Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=46FF63E8-1051-1831-E044-0003BA3F9857

Lung Cancer NCT00738881 On-Study - North Central Cancer Treatment Group Baseline CD Submission Form - 2731639v1.0 - North Central Cancer Treatment Group Baseline CD Submission Form

- 08/01/2015 - 1 Formulaire, 3 Groupes Item, 17 Eléments de données, 1 Langue

Groupes Item: Header Module, Header, Completed by VIEW Personnel:

North Central Cancer Treatment Group Baseline CD Submission Form Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=46FF5830-748C-163A-E044-0003BA3F9857

Lung Cancer NCT00738881 Toxicity - North Central Cancer Treatment Group N0723 Baseline Adverse Events Form - 2731396v1.0 - North Central Cancer Treatment Group N0723 Baseline Adverse Events Form

- 08/01/2015 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 1 Langue

Groupes Item: Header Module, Required Baseline Adverse Events from Section 10.0 of Protocol

North Central Cancer Treatment Group N0723 Baseline Adverse Events Form Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=46FC7080-5A71-1051-E044-0003BA3F9857

SOUTHWEST ONCOLOGY GROUP S0205 BASELINE PHYSICAL EXAMINATION FORM NCT00075686

- 20/09/2021 - 1 Formulaire, 2 Groupes Item, 23 Eléments de données, 1 Langue

Groupes Item: Header, Physical examination

SOUTHWEST ONCOLOGY GROUP S0205 BASELINE PHYSICAL EXAMINATION FORM NCT00075686 S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F2FD44E4-4DFA-66A0-E034-0003BA3F9857

On-Study - Curative Treatment for Head and Neck Cancer - On-Study Form - 2268312v3.0 - Curative Treatment for Head and Neck Cancer - On-Study Form

- 20/09/2021 - 1 Formulaire, 5 Groupes Item, 48 Eléments de données, 1 Langue

Groupes Item: CRF Header, Head & Neck: Form Administration, Head & Neck: Patient Assessment, Head & Neck: Disease Description, Head & Neck: Prior Health History - Curative

Curative Treatment for Head and Neck Cancer - On-Study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D4976276-569A-5CEB-E034-0003BA12F5E7

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.